15/02/2026, Sunday19:16

EDITION :

Today Sports Economy Türkiye World Columns Technology Life Video Gallery Cartoon

Israeli airstrikes killed nine Palestinians Sunday in separate attacks across the Gaza Strip, marking another violation of the October 2025 ceasefire agreement. Medical sources confirmed five deaths southwest of Khan Younis in the south, while paramedics reported four killed when a drone struck a tent sheltering displaced families near Jabalia in the north, as Israeli forces also conducted home demolitions and artillery shelling.Israeli airstrikes killed nine Palestinians Sunday in separate attacks across the Gaza Strip, marking another violation of the October 2025 ceasefire agreement. Medical sources confirmed five deaths southwest of Khan Younis in the south, while paramedics reported four killed when a drone struck a tent sheltering displaced families near Jabalia in the north, as Israeli forces also conducted home demolitions and artillery shelling.A high-level Turkish delegation met with Syrian Information Minister Hamza Mustafa in Damascus to formalize institutional cooperation in combating disinformation, crisis communication, and public diplomacy. The mechanism will operate around the clock.Turkish Foreign Minister Hakan Fidan says Washington appears ready to accept limited Iranian uranium enrichment, and Tehran genuinely seeks a deal. He warns that pressing missiles and proxies simultaneously will stall talks—and may trigger another war.Turkish President Recep Tayyip Erdoğan appointed new ministers of justice and interior through presidential decrees published Tuesday. Istanbul Chief Public Prosecutor Akin Gürlek becomes justice minister, while Erzurum Governor Mustafa Çiftçi takes over the interior ministry.

Israeli airstrikes killed nine Palestinians Sunday in separate attacks across the Gaza Strip, marking another violation of the October 2025 ceasefire agreement. Medical sources confirmed five deaths southwest of Khan Younis in the south, while paramedics reported four killed when a drone struck a tent sheltering displaced families near Jabalia in the north, as Israeli forces also conducted home demolitions and artillery shelling.Israeli airstrikes killed nine Palestinians Sunday in separate attacks across the Gaza Strip, marking another violation of the October 2025 ceasefire agreement. Medical sources confirmed five deaths southwest of Khan Younis in the south, while paramedics reported four killed when a drone struck a tent sheltering displaced families near Jabalia in the north, as Israeli forces also conducted home demolitions and artillery shelling.A high-level Turkish delegation met with Syrian Information Minister Hamza Mustafa in Damascus to formalize institutional cooperation in combating disinformation, crisis communication, and public diplomacy. The mechanism will operate around the clock.Turkish Foreign Minister Hakan Fidan says Washington appears ready to accept limited Iranian uranium enrichment, and Tehran genuinely seeks a deal. He warns that pressing missiles and proxies simultaneously will stall talks—and may trigger another war.Turkish President Recep Tayyip Erdoğan appointed new ministers of justice and interior through presidential decrees published Tuesday. Istanbul Chief Public Prosecutor Akin Gürlek becomes justice minister, while Erzurum Governor Mustafa Çiftçi takes over the interior ministry.

Advertisement

Pfizer to acquire Biohaven Pharmaceuticals in $11.6B cash deal

16:02, 10/05/2022, Tuesday

AA

Pfizer to acquire Biohaven Pharmaceuticals in $11.6B cash deal

File photo

Biohaven known for developing migraine treatment, prevention of it in adults

US-based multinational biotechnology firm Pfizer announced Tuesday it will acquire Biohaven Pharmaceuticals in an $11.6 billion cash deal.

The two companies have entered into a definitive agreement, in which the boards of directors of both firms unanimously approved the transaction.

Pfizer will pay $148.50 per share in cash to buy outstanding shares of Biohaven, according to a statement.

Despite closing Monday with a 7.9% decline, Biohaven's stock price soared 70.2% to $141.50 per share on the New York Stock Exchange during pre-market hours on Tuesday.

Biohaven is best known for developing a migraine therapy for acute treatment and prevention of migraine in adults.

Advertisement

Titles :Pfizer Biohaven Pharmaceuticals US cash deal

Comments

Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.